Review

Pathology

. 2024 Nov 20:S0031-3025(24)00300-3.

doi: 10.1016/j.pathol.2024.11.001. Online ahead of print.

Neuropathology meets chemical and genetic pathology head-on: a personal perspective

Colin L Masters ¹

Affiliations Expand

• PMID: 39668075

DOI: 10.1016/j.pathol.2024.11.001

Abstract

Medical science has made revolutionary discoveries around the nosology and aetiology of the neurodegenerative diseases. Dementia is the second leading cause of death in Australia. My colleagues and I are now looking at therapeutics which potentially can delay or prevent the onset of Alzheimer's disease (AD). Advances in diagnosis allow detection of preclinical AD. Neuropathologists working closely with chemical and genetic pathologists have a major role to play in pushing diagnostics and therapeutics to the forefront of clinical management of these diseases.



Why does he make this statement? He has been doing the same thing all his life, but now he writes it in a journal. He has PBT2 patent license. Something new will be happening. I have no access to this paper, but I am curious it there is anything what could relate ATH.